UBS Raises Altria Price Target Amid Signs of Slowing Cigarette Volume Decline

UBS has raised its price target for Altria Group (MO) to $85 per share, reflecting a more optimistic view on the trajectory of cigarette consumption in the United States. The firm noted a recent slowdown in the rate of volume decline across the tobacco sector, suggesting that the industry may be approaching a stabilization point after years of steady contraction. The revision is based on recent data indicating that annual cigarette volume reductions have tapered to approximately 2.5% in 2025, down from an average of 3.8% in the prior three years. UBS attributes this deceleration to a combination of regulatory pressures plateauing and the continued growth of alternative nicotine products, including vaping and smokeless tobacco, which are partially offsetting traditional cigarette declines. Altria’s portfolio, which includes a controlling stake in Juul and a strong presence in the U.S. cigarette market, is positioned to benefit from this shifting dynamic. The company’s adjusted earnings per share are projected to grow at a compound annual rate of 4.2% through 2027, according to UBS, supported by disciplined cost management and continued dividend growth. The upgrade could influence investor positioning in consumer staples, particularly among tobacco-focused equities. Competitors such as Procter & Gamble (PG) and Coca-Cola (KO), which have exposure to broader consumer goods but not direct tobacco operations, may see indirect sentiment effects as investors reassess the resilience of mature consumer businesses.